Class summary at a glance.

Every drug in the Hydrolytic Lysosomal Glucocerebroside-specific Enzyme class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 3tracked in Part D
CY24 Part D spend: $39.1Mcombined across class
Total Rx claims: 1K124 unique beneficiaries
Generic mfrs (active): 0across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

Imiglucerase

Brand: Cerezyme · 671 Part D claims (CY24) · 76 beneficiaries · First FDA approval: 1994-05-23

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend $21.2M

Class share

54%

of class CY24 spend

View profile →

Velaglucerase Alfa

Brand: VPRIV · 426 Part D claims (CY24) · 48 beneficiaries · First FDA approval: 2010-02-26

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend $14.0M

Class share

36%

of class CY24 spend

View profile →

Taliglucerase Alfa

Brand: ELELYSO · 87 Part D claims (CY24) · First FDA approval: 2012-05-01

Brand-only (no generics)

Low NADAC—

→

Avg plan cost—

Part D spend $3.9M

Class share

10%

of class CY24 spend

View profile →

Class summary at a glance.

Every drug in this class, ranked by Part D spend.

Related questions.